Expression: evidence from lesion and chronic cholinergic
Drug treatment studies // Neuroscience. — 1993. — par Vol. 52, N 3. — P. 575 – 85.
Le A. D., Kiianmaa K., Cunningham C. L. et al. Neurobiological
Processes in alcohol addiction // Alcohol. Clin. Exp.
Res. — 2001. — Vol. 25, Suppl. 5. (ISBRA) — P. 144S – 51S.
Lebedewa N. M., Lunew D. K., Dschibladse D. M. et al. Die
Behandlung mit Cerebrolysin bei Patienten mit Hirndurchblutungsst ö rungen
// II Symposium on Cerebrolysin. — par M., 1975. — Р . 7 – 1.
288. Lenz H. Aminos ä uregemisch bei Petit mal und narkoleptischen
// Anf ä llen Wien Med. Wochenschr. — 1954. — par N 26/27. — Р . 531 – 32.
Lindner G., Grosse G., Matthies H., Kirsche W. Effects of
Brain extract and hydrolysate on nerve tissue in vitro // Z.
Mikrosk. Anat. Forsch. — 1975. — N 89 (5). — Р . 815 – 23.
Lombardi V., Ccabelos R., Perez P. et al. Cerebrolysin improves
Memory performance and the brain bioelectrical
Activity pattern in elderly humans // Neurobiol. Aging. — par 2000. — Vol. 21, N 1S. — P. S67.
Lombardi V. R., Windisch M., Garcia M., Cacabelos R.
Effects of Cerebrolysin on in vitro primary microglial and
Astrocyte rat cell cultures // Methods Find Exp. Clin. Pharmacol.
— 1999. — N 21 (5). — Р . 331 – 38.
Mallory M., Honer W., Hsu L. et al. In vitro synaptotrophic
Effects of Cerebrolysin in NT2N cells // Acta Neuropathol.
(Berl). — 1999. — N 97 (5). — Р . 437 – 46.
Masliah E., Armasolo F., Veinbergs I. et al. Cerebrolysin
Ameliorates performance deficits, and neuronal damage
In apolipoprotein Edeficient mice // Pharmacol. Biochem.
Behav. — 1999. — Vol. 62. — P. 239 – 45.
Matula C., Schoeggl A. Cerebral protection before, during
And after neurosurgical procedures // Stereotact. Funct.
Neurosurg. — 2000. — N 75 (2 – ). — Р . 142 – 46.
Markowa E. D., Iwanowa-Smolenskaja J. A., Insarowa
N. G. et al. Cerebrolysin bei der Behandlung einiger
Erblicher Krankheiten des Nervensystems // II Symposium
On Cerebrolysin. — M., 1975. — Р . 12 – 5.
НУu1095 чНu1067 ЫЕОu1041 БЗu1054 ОРu1067 Ы
Тu1054 ОМ7/2009/4 Оu1041 БЗu1054 ОРu1067 Ы Пu1054 О Кu1051 ЛИu1053 НИu1063 ЧЕu1057 СКu1054 ОЙФu1040 АРu1052 МАu1050 КОu1051 ЛОu1043 ГИu1048 И ИЛu1045 ЕКu1040 АРu1057 СТu1042 ВЕu1053 ННu1054 ОЙТu1045 ЕРu1040 АПu1048 ИИ 73
|
|
|
296. Moessler H. Новые данные о церебролизине :
эффективность , базирующаяся на доказательствах //
Фарматека . — 2007. — Т . 42, N 6. — Р . 33 – 2.
Muresanu D. F., Rainer M., Moessler H. Improved global
function and activities of daily living in patients with AD:
A placebo-controlled clinical study with the neurotrophic
Agent Cerebrolysin // J. Neural. Transm. Suppl. — 2002. — par N 62. — Р . 277 – 85.
Ono T., Takahashi M., Nakamura Y. et al. Cerebrolysin injection
— one time administration and a repetitive administration
Test // Internal Report on phase I clinical trial of
FPF-1070. — 1988. — 36 р .
Ono T., Takahashi M., Nakamura Y. et al. Phase I study of
FPF 1070 (Cerebrolysin) ampouls in healthy volunteers — par single and multiple dose study // Jpn. J. Pharmacol. — par 1992. — N 20 (4). — Р . 1213 – 229.
Mosmann T. R., Sad S. The expanding universe of T-cell
Subsets: Th1, Th2 and more // Immunol. Today. — 1996. — par N 17. — Р . 138 – 46.
Panisset M., Gauthier S., Moessler H., Windisch M. Cerebrolysin
In Alzheimer ’ s disease: a randomized, double-blind,
Placebo-controlled trial with a neurotrophic agent // J. Neural.
Transm. — 2002. — Vol. 109, N 7 – . — Р . 1089 – 104.
Perlick D., Mattis S. Neuropsychological assessment in
Chronic care settings: potential utility and special considerations
For evaluating dementia in the elderly //Alzheimer Dis.
Assoc. Disord. — 1994. — Vol. 8, Suppl. 1. — S 209 – 13.
303. Petersen I-M., B ö rop C., Brun B. Pilotforsog med cerebrolysin
Til dementer patienter // Nordisk Psykiatrisk
|
|
|
Tidsskrift. — 1979. — N 33. — Р . 594 – 98.
Philips M. F., Mattiasson G., Wieloch T. et al. Neuroprotective
And behavioral efficacy of NGF-transfected hippocampal
Progenitor cell transplants after experimental
Traumatic brain injury // J. Neurosurg. — 2001. — N 94
(5). — Р . 765 – 74.
Prevalence off autism in Brick Township. — New Jercey. — par Community Report, 1998.
Pruszewicz A., Obrebowski A., Woznica B., Swidzinski P.
Pharmacological possibilities in treatment hypoacusis in
Children // Otolaryngol. Pol. — 1994. — N 48(1). — Р . 63 – 6.
Quandt J., Walter L. Problematic des Cerebrolysineffects
Bei Neugeborenen // II Symposium on Cerebrolysin. — par M., 1975. — Р . 46 – 9.
Radmayr E. P. Cerebrolysin bei einer unterbegabten Anfallskranken
// Р rakt. Arzt. — 1957. — N 123. — Р . 578 – 81.
309. Reca T., de Matera C., Taubenschlag H. et al. Vorl ä ufiger
Bericht ü ber pharmakologische Versuche (Chemotherapie
Und biologische Produkte) bei der Behandlung der geistigen
Demenz // II Kongre ß f ü r Psychiatrie. — 1960. — Р . 44 – 6.
Reinprecht I., Gschanes A., Windisch M., Fachbach G.
Two peptidergic drugs increase the synaptophysin immunoreactivity
In brains of 24-month-old rats // J. Histochem.
— 1999. — N 31 (6). — Р . 395 – 01.
Rischke R., Krieglstein J. Effects of vinpocetine on local
Дата добавления: 2018-09-22; просмотров: 137; Мы поможем в написании вашей работы! |
Мы поможем в написании ваших работ!